Abiogen Pharma SpA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Abiogen Pharma SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3399
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abiogen Pharma SpA (Abiogen), a subsidiary of MDM Holding SpA, is a specialist pharmaceutical company, which develops, manufactures, and markets medicines with focus on musculo-skeletal health, and rare diseases. The company offers products in the form of oral solids, injectables, semi solids, oral liquids, food supplements, and cosmetics for the treatment of hypovitaminosis D, dermatology, bone metabolism, pain and viscosupplementation, respiratory conditions, and diabetes. Abiogen’s service offerings include contract manufacturing, licensing, pharmacovigilance, clinical trial supply, quality assurance, and integrated pharmaceutical development services such as pre-formulation, process optimization and scale-up, clinical manufacturing and technology transfer and validation. The company markets its products through a network of distributors in Italy. Abiogen is headquartered in Pisa, Italy.

Abiogen Pharma SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abiogen Pharma SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Abiogen Pharma Enters Into Distribution Agreement With EffRx For Binosto 10
Licensing Agreements 11
Abiogen Pharma Enters into Licensing Agreement with Lee’s Pharma for Thorens Cholecalciferol 11
Abiogen Pharma Enters into Licensing Agreement with Lee’s Pharma for Attila 12
Grunenthal Enters into Licensing Agreement with Abiogen Pharma 13
Abiogen Pharma SpA – Key Competitors 14
Abiogen Pharma SpA – Key Employees 15
Abiogen Pharma SpA – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Key Facts 2
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abiogen Pharma SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abiogen Pharma SpA, Deals By Therapy Area, 2012 to YTD 2018 8
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abiogen Pharma Enters Into Distribution Agreement With EffRx For Binosto 10
Abiogen Pharma Enters into Licensing Agreement with Lee's Pharma for Thorens Cholecalciferol 11
Abiogen Pharma Enters into Licensing Agreement with Lee's Pharma for Attila 12
Grunenthal Enters into Licensing Agreement with Abiogen Pharma 13
Abiogen Pharma SpA, Key Competitors 14
Abiogen Pharma SpA, Key Employees 15

List of Figures
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Abiogen Pharma SpA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Musgrave Group Plc:戦略・SWOT・企業財務分析
    Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report Summary Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • IDL Biotech AB (IDL B):企業の財務・戦略的SWOT分析
    Summary IDL Biotech AB (IDL Biotech) is a biotechnology company that develops, manufactures and markets vitro diagnostic tests. The company offers products in the clinical areas of oncology and bacteriology. It offers vitro diagnostic tumor activity markers for common types of cancer which include b …
  • Securian Financial Group, Inc.:企業の戦略・SWOT・財務情報
    Securian Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Securian Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Divergent Energy Services Corp (DVG):石油・ガス:M&Aディール及び事業提携情報
    Summary Divergent Energy Services Corp (Divergent Energy), formerly CDN Oilfield Technologies and Solutions Corp is an energy service company that offers artificial lift technologies for the oil and gas industry. The company offers products such as electromagnetic submersible pumps and electric subm …
  • Acorda Therapeutics Inc (ACOR):企業の財務・戦略的SWOT分析
    Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • NXT Energy Solutions Inc (SFD):石油・ガス:M&Aディール及び事業提携情報
    Summary NXT Energy Solutions Inc (NXT Energy), formerly Energy Exploration Technologies Inc is an oilfield service company that offers geophysical services to the upstream oil and gas industry. The company provides Stress Field Detection (SFD) a patent pending gravity-based instrument that provides …
  • SQI Diagnostics Inc (SQD):医療機器:M&Aディール及び事業提携情報
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. The company provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop …
  • The Save Mart Companies:戦略・SWOT・企業財務分析
    The Save Mart Companies - Strategy, SWOT and Corporate Finance Report Summary The Save Mart Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Avanos Medical Inc (HYH):医療機器:M&Aディール及び事業提携情報
    Summary Avanos Medical Inc (Avanos Medical), formerly Halyard Health Inc is a medical technology company that provides medical devices and equipments. The company offers clinically-superior products and solutions in digestive health, pain management, infection prevention, surgical solutions and IV t …
  • Pernix Therapeutics Holdings Inc (PTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • Pulse Seismic Inc (PSD):企業の財務・戦略的SWOT分析
    Summary Pulse Seismic Inc (Pulse), formerly Pulse Data Inc is a provider of seismic data library for oil and gas exploration. The company acquires, markets and licenses 2D and 3D seismic data to the western Canadian energy sector. It offers services such as project cost tracking, scouting, geophysic …
  • Redhall Group Plc:企業の戦略・SWOT・財務情報
    Redhall Group Plc - Strategy, SWOT and Corporate Finance Report Summary Redhall Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fox Chase Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Fox Chase Cancer Center (Fox Chase), formerly American Oncologic Hospital Inc, a subsidiary of Temple University Health System Inc, is a healthcare service provider that offers cancer care services. The center provides screening services for breast, colorectal, prostate, lung and skin cancer …
  • Time Technoplast Ltd.:戦略・SWOT・企業財務分析
    Time Technoplast Ltd. - Strategy, SWOT and Corporate Finance Report Summary Time Technoplast Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Monsanto Company:企業のM&A・事業提携・投資動向
    Monsanto Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Monsanto Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Toppan Forms Co., Ltd.:企業の戦略・SWOT・財務情報
    Toppan Forms Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toppan Forms Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Trammo Inc.:企業の戦略・SWOT・財務情報
    Trammo Inc. - Strategy, SWOT and Corporate Finance Report Summary Trammo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Swinerton Inc:企業の戦略的SWOT分析
    Swinerton Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • PizzaExpress Limited:企業の戦略・SWOT・財務情報
    PizzaExpress Limited - Strategy, SWOT and Corporate Finance Report Summary PizzaExpress Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GRP Limited (GRPLTD):企業の財務・戦略的SWOT分析
    GRP Limited (GRPLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆